Therapy for methicillin-resistant Staphylococcus aureus [1]

New England Journal of Medicine

Volumn 355, Issue 20, 2006, Pages 2153-

  Siegman Igra, Yardena ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; METICILLIN; PENICILLIN G; VANCOMYCIN;

DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; HUMAN; LETTER; MEDICAL INFORMATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

EID: 33750975334     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc062516     Document Type: Letter

References (3)

1. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-65.
2. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003;82:333-9.
3. Siegman-Igra Y, Reich P, Orni-Wasserlauf R, Schwartz D, Giladi M. The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia. Scand J Infect Dis 2005;37:572-8.